Research ExplorerPublicationsHandlungsempfehlungen der Deutschen Gesellschaft für Rheumat...

Handlungsempfehlungen der Deutschen Gesellschaft für Rheumatologie e. V. für die Betreuung von Patienten mit entzündlich rheumatischen Erkrankungen im Rahmen der SARS-CoV-2/COVID-19-Pandemie – Update Juli 2020

Standard

Handlungsempfehlungen der Deutschen Gesellschaft für Rheumatologie e. V. für die Betreuung von Patienten mit entzündlich rheumatischen Erkrankungen im Rahmen der SARS-CoV-2/COVID-19-Pandemie – Update Juli 2020. / Schulze-Koops, Hendrik; Iking-Konert, Christof; Leipe, Jan; Hoyer, Bimba Franziska; Holle, Julia; Moosig, Frank; Aries, Peer; Burmester, Gerd; Fiehn, Christoph; Krause, Andreas; Lorenz, Hanns-Martin; Schneider, Matthias; Sewerin, Philipp; Voormann, Anna; Wagner, Ulf; Krüger, Klaus; Specker, Christof; Kommission Pharmakotherapie.

In: Z RHEUMATOL, Vol. 79, No. 7, 09.2020, p. 679-685.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Schulze-Koops, H, Iking-Konert, C, Leipe, J, Hoyer, BF, Holle, J, Moosig, F, Aries, P, Burmester, G, Fiehn, C, Krause, A, Lorenz, H-M, Schneider, M, Sewerin, P, Voormann, A, Wagner, U, Krüger, K, Specker, C & Kommission Pharmakotherapie 2020, 'Handlungsempfehlungen der Deutschen Gesellschaft für Rheumatologie e. V. für die Betreuung von Patienten mit entzündlich rheumatischen Erkrankungen im Rahmen der SARS-CoV-2/COVID-19-Pandemie – Update Juli 2020', Z RHEUMATOL, vol. 79, no. 7, pp. 679-685. https://doi.org/10.1007/s00393-020-00851-x

APA

Schulze-Koops, H., Iking-Konert, C., Leipe, J., Hoyer, B. F., Holle, J., Moosig, F., Aries, P., Burmester, G., Fiehn, C., Krause, A., Lorenz, H-M., Schneider, M., Sewerin, P., Voormann, A., Wagner, U., Krüger, K., Specker, C., & Kommission Pharmakotherapie (2020). Handlungsempfehlungen der Deutschen Gesellschaft für Rheumatologie e. V. für die Betreuung von Patienten mit entzündlich rheumatischen Erkrankungen im Rahmen der SARS-CoV-2/COVID-19-Pandemie – Update Juli 2020. Z RHEUMATOL, 79(7), 679-685. https://doi.org/10.1007/s00393-020-00851-x

Vancouver

Schulze-Koops H, Iking-Konert C, Leipe J, Hoyer BF, Holle J, Moosig F et al. Handlungsempfehlungen der Deutschen Gesellschaft für Rheumatologie e. V. für die Betreuung von Patienten mit entzündlich rheumatischen Erkrankungen im Rahmen der SARS-CoV-2/COVID-19-Pandemie – Update Juli 2020. Z RHEUMATOL. 2020 Sep;79(7):679-685. https://doi.org/10.1007/s00393-020-00851-x

Bibtex

@article{f4ffb3717f99499abc976bb9d7ae7fcb,
title = "Handlungsempfehlungen der Deutschen Gesellschaft f{\"u}r Rheumatologie e. V. f{\"u}r die Betreuung von Patienten mit entz{\"u}ndlich rheumatischen Erkrankungen im Rahmen der SARS-CoV-2/COVID-19-Pandemie – Update Juli 2020",
abstract = "A few days after the SARS-CoV-2 infection was declared a pandemic, the German Society for Rheumatology (DGRh) compiled first recommendations for the care of patients with inflammatory rheumatic diseases (IRD). These first recommendations were based on an expert consensus and were largely non-evidence-based. Now that the first scientific data from registers, cross-sectional studies, case reports and case series are available, the present update is intended to update the previous recommendations and to add new findings. The current recommendations are based on a literature search of publications available up to 15 June 2020 and address preventive measures (such as hygiene measures or vaccinations) and the use of immunomodulatory/immunosuppressive drugs. An important goal of the current recommendations is also to prevent harm to patients with IRD through unjustified restriction of care. The DGRh will continue to update its recommendations in the case of new aspects and will publish them as well as further information on the COVID-19 pandemic on its homepage ( www.dgrh.de ) in an ongoing process.",
keywords = "Betacoronavirus, COVID-19, Coronavirus Infections/epidemiology, Germany, Humans, Inflammation/therapy, Pandemics, Pneumonia, Viral/epidemiology, Rheumatic Diseases/therapy, Rheumatology/methods, SARS-CoV-2, Societies, Medical",
author = "Hendrik Schulze-Koops and Christof Iking-Konert and Jan Leipe and Hoyer, {Bimba Franziska} and Julia Holle and Frank Moosig and Peer Aries and Gerd Burmester and Christoph Fiehn and Andreas Krause and Hanns-Martin Lorenz and Matthias Schneider and Philipp Sewerin and Anna Voormann and Ulf Wagner and Klaus Kr{\"u}ger and Christof Specker and {Kommission Pharmakotherapie}",
year = "2020",
month = sep,
doi = "10.1007/s00393-020-00851-x",
language = "Deutsch",
volume = "79",
pages = "679--685",
journal = "Z RHEUMATOL",
issn = "0340-1855",
publisher = "D. Steinkopff-Verlag",
number = "7",

}

RIS

TY - JOUR

T1 - Handlungsempfehlungen der Deutschen Gesellschaft für Rheumatologie e. V. für die Betreuung von Patienten mit entzündlich rheumatischen Erkrankungen im Rahmen der SARS-CoV-2/COVID-19-Pandemie – Update Juli 2020

AU - Schulze-Koops, Hendrik

AU - Iking-Konert, Christof

AU - Leipe, Jan

AU - Hoyer, Bimba Franziska

AU - Holle, Julia

AU - Moosig, Frank

AU - Aries, Peer

AU - Burmester, Gerd

AU - Fiehn, Christoph

AU - Krause, Andreas

AU - Lorenz, Hanns-Martin

AU - Schneider, Matthias

AU - Sewerin, Philipp

AU - Voormann, Anna

AU - Wagner, Ulf

AU - Krüger, Klaus

AU - Specker, Christof

AU - Kommission Pharmakotherapie

PY - 2020/9

Y1 - 2020/9

N2 - A few days after the SARS-CoV-2 infection was declared a pandemic, the German Society for Rheumatology (DGRh) compiled first recommendations for the care of patients with inflammatory rheumatic diseases (IRD). These first recommendations were based on an expert consensus and were largely non-evidence-based. Now that the first scientific data from registers, cross-sectional studies, case reports and case series are available, the present update is intended to update the previous recommendations and to add new findings. The current recommendations are based on a literature search of publications available up to 15 June 2020 and address preventive measures (such as hygiene measures or vaccinations) and the use of immunomodulatory/immunosuppressive drugs. An important goal of the current recommendations is also to prevent harm to patients with IRD through unjustified restriction of care. The DGRh will continue to update its recommendations in the case of new aspects and will publish them as well as further information on the COVID-19 pandemic on its homepage ( www.dgrh.de ) in an ongoing process.

AB - A few days after the SARS-CoV-2 infection was declared a pandemic, the German Society for Rheumatology (DGRh) compiled first recommendations for the care of patients with inflammatory rheumatic diseases (IRD). These first recommendations were based on an expert consensus and were largely non-evidence-based. Now that the first scientific data from registers, cross-sectional studies, case reports and case series are available, the present update is intended to update the previous recommendations and to add new findings. The current recommendations are based on a literature search of publications available up to 15 June 2020 and address preventive measures (such as hygiene measures or vaccinations) and the use of immunomodulatory/immunosuppressive drugs. An important goal of the current recommendations is also to prevent harm to patients with IRD through unjustified restriction of care. The DGRh will continue to update its recommendations in the case of new aspects and will publish them as well as further information on the COVID-19 pandemic on its homepage ( www.dgrh.de ) in an ongoing process.

KW - Betacoronavirus

KW - COVID-19

KW - Coronavirus Infections/epidemiology

KW - Germany

KW - Humans

KW - Inflammation/therapy

KW - Pandemics

KW - Pneumonia, Viral/epidemiology

KW - Rheumatic Diseases/therapy

KW - Rheumatology/methods

KW - SARS-CoV-2

KW - Societies, Medical

U2 - 10.1007/s00393-020-00851-x

DO - 10.1007/s00393-020-00851-x

M3 - SCORING: Review

C2 - 32757030

VL - 79

SP - 679

EP - 685

JO - Z RHEUMATOL

JF - Z RHEUMATOL

SN - 0340-1855

IS - 7

ER -